Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label cancer risk. Show all posts
Showing posts with label cancer risk. Show all posts

Wednesday, June 18, 2025

Why Donating Blood Frequently May Reduce Your Risk of Cancer

 

 I'm O negative(Univesal donor) so I'm very popular. So far about 5 gallons in 10 years.

Why Donating Blood Frequently May Reduce Your Risk of Cancer

Being a good Samaritan may pay off even more than you thought. While donating blood is a selfless act that can save lives and help address an urgent public health need in the U.S., there might be a good selfish reason to do it, too.

A new study from researchers at the Francis Crick Institute in London determined that giving blood often may result in genetic changes in our blood stem cells that help prevent cancers like leukemia from developing. When comparing frequent donors (individuals who gave blood three times annually over 40 years) to sporadic ones (those who gave blood fewer than 10 times total), the scientists found that the former were more likely to have favorable genetic mutations in their stem cells.

Hector Huerga Encabo

“Our work is a fascinating example of how our genes interact with the environment and as we age,” senior author Dominique Bonnet said in a news release. “Activities that put low levels of stress on blood cell production allow our blood stem cells to renew and we think this favors mutations that further promote stem cell growth rather than disease.”

Analyzing blood from over 200 men in each category, the scientists zoomed in on hematopoietic stem cells (HSCs), aka blood stem cells. These cells naturally mutate as we age, which leads to clones with subtly different genetic makeup, a process known as clonal hematopoiesis. While this is normal, certain mutations can cause blood cancers.


Giving blood didn’t affect the cells’ likelihood of undergoing clonal hematopoiesis — it was found to be just as common in frequent donors versus sporadic. However, the researchers noticed that the genetic makeup of blood cells in each group varied when it came to a gene called DNMT3A, which is known to mutate in people who develop leukemia.   

Hector Huerga Encabo

This finding spurred the team — who collaborated with scientists in Heidelberg, Germany, with the help of the German Red Cross Blood Donation Center — to conduct follow-up experiments. They decided to edit human HSCs using CRISPR, and then implant the edited cells in mice. The result? When the mice that had blood removed were then exposed to stress imitating that of frequent blood loss, the cells with DNMT3A mutations produced red blood cells to recoup blood supply, and those new cells didn’t turn cancerous. 

MicrovOne/ iStock

“Our sample size is quite modest, so we can’t say that blood donation definitely decreases the incidence of pre-leukemic mutations and we will need to look at these results in much larger numbers of people,” Bonnet said. “It might be that people who donate blood are more likely to be healthy if they’re eligible, and this is also reflected in their blood cell clones. But the insight it has given us into different populations of mutations and their effects is fascinating.”

While the researchers can’t yet say for sure that donating blood often makes you less likely to develop leukemia, they theorize that doing so can reduce your chances of developing early blood cancer mutations.

“We had to look at a very specific group of people to spot subtle genetic differences which might actually be beneficial in the long-term,” said Hector Huerga Encabo, postdoctoral fellow in the Haematopoietic Stem Cell Laboratory at the Crick. “We’re now aiming to work out how these different types of mutations play a role in developing leukemia or not, and whether they can be targeted therapeutically.” 

RELATED: “Hungry” Fat Cells Could Fight Cancer by Devouring Tumors’ Food Sources, Study Suggests

Sunday, January 26, 2025

Red Wine May Not Be a Health Tonic, but Is It a Cancer Risk?

 

Not changing my mind for the couple days a week I go to bars for music and socializing which is going to prevent dementia. Vastly more important to have quality of life than worry about cancer.

I'm using it for social connections for prevention of dementia thus I'm ignoring the cons because I think the benefits exceed the cons. But I'm not medically trained so don't listen to me. 

Resveratrol in red wine is supposedly good for you. The testing in mice, according to researchers, this amount of resveratrol equated to the amount found in approximately 1,000 bottles of red wine. (Is that a daily dose of 1000 bottles of wine?)

Alcohol for these 12 reasons. None of these are valid according to this.

Red Wine May Not Be a Health Tonic, but Is It a Cancer Risk?

The evidence is clear: Alcohol can cause cancer.

Earlier this month, US surgeon general Vivek Murthy, MD, issued an advisory, calling for alcoholic beverages to carry a warning label about cancer risk. The advisory flagged alcohol as the third leading preventable cause of cancer in the United States, after tobacco and obesity, and highlighted people's limited awareness about the relationship between alcohol and cancer risk.

But, when it comes to cancer risk, are all types of alcohol created equal?

For many years, red wine seemed to be an outlier, with studies indicating that, in moderation, it might even be good for you. Red wine has anti-inflammatory and antioxidant properties — most notably, it contains the antioxidant resveratrol. Starting in the 1990s, research began to hint that the compound might protect against heart disease, aging, and cancer, though much of this work was done in animals or test tubes.

The idea that red wine carries health benefits, however, has been called into question more recently. A recent meta-analysis, for instance, suggests that many previous studies touting the health benefits of more moderate drinking were likely biased, potentially leading to "misleading positive health associations." And one recent study found that alcohol consumption, largely red wine and beer, at all levels was linked to an increased risk for cardiovascular disease.

Although wine's health halo is dwindling, there might be an exception: Cancer risk.

Overall, research shows that even light to moderate drinking increases the risk for at least seven types of cancer, but when focusing on red wine, in particular, that risk calculus can look different.

"It's very complicated and nuanced," said Timothy Rebbeck, PhD, professor of cancer prevention, Harvard T.H. Chan School of Public Health, Boston. "And 'complicated and nuanced' doesn't work very well in public health messages."

The Knowns About Alcohol and Cancer Risk

Some things about the relationship between alcohol and cancer risk are crystal clear. "There's no question that alcohol is a group 1 carcinogen," Rebbeck said. "Alcohol can cause cancer."

Groups including the International Agency for Research on Cancer (IARC) and American Cancer Society agree that alcohol use is an established cause of seven types of cancer: Those of the oral cavity, larynx, pharynx, esophagus (squamous cell carcinoma), liver (hepatocellular carcinoma), breast, and colon/rectum. Heavy drinking — at least 8 standard drinks a week for women and 15 for men — and binge drinking — 4 or more drinks in 2 hours for women and 5 or more for men — only amplify that risk. (A "standard" drink has 14 g of alcohol, which translates to a 5-oz glass of wine.)

"We're most concerned about high-risk drinking — more than 2 drinks a day — and/or binge drinking," said Noelle LoConte, MD, from the Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, who authored a 2018 statement on alcohol and cancer risk from the American Society of Clinical Oncology (ASCO).

Compared with not drinking, heavy drinking is linked with a roughly fivefold increase in the risk for oral cavity, pharyngeal, and esophageal cancers, and a 61% increase in the risk for breast cancer, according to LoConte and colleagues.

Things get murkier when it comes to moderate drinking — defined as up to 1 standard drink per day for women and 2 per day for men. There is evidence, LoConte said, that moderate drinking is associated with increased cancer risks, though the magnitude is generally much less than heavier drinking.

Cancer type also matters. One analysis found that the risk for breast cancer increased with even light to moderate alcohol consumption. Compared with no drinking, light to moderate drinking has also been linked to increased risks for oral cavity, pharynx, larynx, and esophageal cancers.

As for whether the type of alcoholic beverage matters, LoConte said, there's no clear physiological reason that wine would be less risky than beer or liquor. Research indicates that ethanol is the problematic ingredient: Once ingested, it's metabolized into acetaldehyde, a DNA-damaging substance that's considered a probable human carcinogen. Ethanol can also alter circulating levels of estrogens and androgens, LoConte said, which is thought to drive its association with breast cancer risk.

"It likely doesn't matter how you choose to get your ethanol," she said. "It's a question of volume."

Hints That Wine Is an Outlier

Still, some studies suggest that how people ingest ethanol could make a difference.

A study published in August in JAMA Network Open is a case in point. The study found that, among older adults, light to heavy drinkers had an increased risk of dying from cancer, compared with occasional drinkers (though the increased risk among light to moderate drinkers occurred only among people who also had chronic health conditions, such as diabetes or high blood pressure, or were of lower socioeconomic status).

Wine drinkers fared differently. Most notably, drinkers who "preferred" wine — consuming over 80% of total ethanol from wine — or those who drank only with meals showed a small reduction in their risk for cancer mortality and all-cause mortality (hazard ratio [HR], 0.94 for both). The small protective association was somewhat stronger among people who reported both patterns (HR, 0.88), especially if they were of lower socioeconomic status (HR, 0.79).

The findings are in line with other research suggesting that wine drinkers may be outliers when it comes to cancer risk. A 2023 meta-analysis of 26 observational studies, for instance, found no association between wine consumption and any cancer type, with the caveat that there was "substantial" heterogeneity among the studies.

This heterogeneity caveat speaks to the inherent limitations of observational research, said Tim Stockwell, PhD, from the Canadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.

"Individual studies of alcohol and cancer risk do find differences by type of drink, or patterns of drinking," Stockwell said. "But it's so hard to unpack the confounding that goes along with the type of person who's a wine drinker or a beer drinker or a spirit drinker. The beverage of choice seems to come with a lot of baggage."

Compared with people who favor beer or liquor, he noted, wine aficionados are typically higher-income, exercise more often, smoke less, and have different diets, for example. The "best" studies, Rebbeck said, try to adjust for those differences, but it's challenging.

The authors of the 2023 meta-analysis noted that "many components in wine could have anticarcinogenic effects" that theoretically could counter the ill effects of ethanol. Besides resveratrol, which is mainly found in red wine, the list includes anthocyanins, quercetin, and tannins. However, the authors also acknowledged that they couldn't account for whether other lifestyle habits might explain why wine drinkers, overall, showed no increased cancer risks and sometimes lower risks.

Still, groups such as the IARC and ASCO hold that there is no known "safe" level, or type, of alcohol when it comes to cancer.

In the latest Canadian guidelines on alcohol use, the scientific panel calculated that people who have 6 drinks a week throughout adulthood (whatever the source of the alcohol) could shave 11 weeks from their life expectancy, on average, said Stockwell, who was on the guideline panel. Compare that with heavy drinking, where 4 drinks a day could rob the average person of 2 or 3 years. "If you're drinking a lot, you could get huge benefits from cutting down," Stockwell explained. "If you're a moderate drinker, the benefits would obviously be less."

Stockwell said that choices around drinking and breast cancer risk, specifically, can be "tough." Unlike many of the other alcohol-associated cancers, he noted, breast cancer is common — so even small relative risk increases may be concerning. Based on a 2020 meta-analysis of 22 cohort studies, the risk for breast cancer rises by about 10%, on average, for every 10 g of alcohol a woman drinks per day. This study also found no evidence that wine is any different from other types of alcohol.

In real life, the calculus around wine consumption and cancer risk will probably vary widely from person to person, Rebbeck said. One woman with a family history of breast cancer might decide that having wine with dinner isn't worth it. Another with the same family history might see that glass of wine as a stress reliever and opt to focus on other ways to reduce her breast cancer risk — by exercising and maintaining a healthy weight, for example.

"The bottom line is, in human studies, the data on light to moderate drinking and cancer are limited and messy, and you can't draw firm conclusions from them," Rebbeck said. "It probably raises risk in some people, but we don't know who those people are. And the risk increases are relatively small."

A Conversation Few Are Having

Even with many studies highlighting the connection between alcohol consumption and cancer risk, most people remain unaware about this risk.

A 2023 study by the National Cancer Institute found that only a minority of US adults knew that drinking alcohol is linked to increased cancer risk, and they were much less likely to say that was true of wine: Only 20% did, vs 31% who said that liquor can boost cancer risk. Meanwhile, 10% believed that wine helps prevent cancer. Other studies show that even among cancer survivors and patients undergoing active cancer treatment, many drink — often heavily.

"What we know right now is, physicians almost never talk about this," LoConte said.

That could be due to time constraints, according to Rebbeck, or clinicians' perceptions that the subject is too complicated and/or their own confusion about the data. There could also be some "cognitive dissonance" at play, LoConte noted, because many doctors drink alcohol.

It's critical, she said, that conversations about drinking habits become "normalized," and that should include informing patients that alcohol use is associated with certain cancers. Again, LoConte said, it's high-risk drinking that's most concerning and where reducing intake could have the biggest impact on cancer risk and other health outcomes.

"From a cancer prevention standpoint, it's probably best not to drink," she said. "But people don't make choices based solely on cancer risk. We don't want to come out with recommendations saying no one should drink. I don't think the data support that, and people would buck against that advice."

Rebbeck made a similar point. Even if there's uncertainty about the risks for a daily glass of wine, he said, people can use that information to make decisions. "Everybody's preferences and choices are going to be different," Rebbeck said. "And that's all we can really do."

Wednesday, May 24, 2023

Long telomeres may heighten cancer risks

So ask your doctor if you want longer telomeres to help with aging. S/he should know about the controversy and have appropriate knowledge to discuss it. 

Long telomeres may heighten cancer risks

At a Glance

  • People with mutations that lead to excessively long chromosome tips, or telomeres, may be at increased risk for a range of cancers.
  • The findings add another dimension to earlier research suggesting that increased telomere length can slow the aging process and prolong life.
Illustration of X-shaped chromosomes with telomere caps at the end of each arm. Telomeres are structures at the ends of chromosomes that protect them from being broken down. peterschreiber.media / Shutterstock

Telomeres are protective molecular caps at the ends of chromosomes. They keep chromosome tips from being broken down. Telomeres tend to shorten as we get older, because they naturally erode each time cells divide. When telomeres shrink to a certain threshold, the cell stops multiplying or dies.

Shortened telomeres have been linked to age-related disorders and early death in humans. Since long telomeres extend cells’ lifespan, some have suggested that boosting telomere length might help to delay certain age-related illnesses. But longer telomeres might carry their own sets of risks. And the potential health effects of having very long telomeres are poorly understood.

To learn more, a research team led by Dr. Mary Armanios of Johns Hopkins University studied people who have rare mutations that disable a telomere-related gene called POT1. This gene codes for a protein that normally helps to regulate telomere length. Mutations that hinder normal POT1 activity can lead to excessively long telomeres.

The scientists identified 17 people with POT1 mutations from five unrelated families. The people ranged in age from 7 to 83, with most over age 40. Four had died from cancer. The researchers measured telomere length in the participants who were alive. For comparison, they also studied 21 relatives of the participants who didn’t have the POT1 mutations. Findings were described in the New England Journal of Medicine on May 4, 2023.

The team found that all 13 people who were alive had telomeres that were longer on average than those of their relatives without the POT1 mutations. Their telomeres were 90% longer than average. Some of those with the POT1 mutations showed modest signs of slowed aging, such as delayed graying of hair.

However, 15 of the 17 participants with the mutations had some type of abnormal tissue growth, called neoplasms, that ranged from benign to cancerous. Eight had different types of the skin cancer melanoma. Seven had thyroid neoplasms, including thyroid cancer and goiters. The most life-threatening neoplasm was malignant glioma, a type of brain cancer that affected two participants.

In addition, five of the participants with the POT1 mutations had different types of blood-related cancers. Eight of 12 (67%) people analyzed also had an age-related blood condition called CHIP (clonal hematopoiesis of indeterminate potential). CHIP typically affects only about 10 to 20% of adults over the age of 70. It has been linked to an increased risk for blood and other cancers. The team found evidence that faulty POT1 activity can allow cancerous blood cells to grow and proliferate because they’re unchecked by the normal cell death that occurs when telomeres shorten.

These findings challenge the idea that strategies to lengthen telomeres could effectively protect against aging. “Cells with very long telomeres accumulate mutations and appear to promote tumors and other types of growths that would otherwise be put in check by normal telomere shortening processes,” Armanios says.

Friday, February 14, 2020

Coffee drinking and cancer risk: an umbrella review of meta-analyses of observational studies

I understood absolutely nothing here. But I'm doing all my coffee for these reasons, don't listen to me, I'm not medically trained. 

How coffee protects against Parkinson’s Aug. 2014 

 Coffee May Lower Your Risk of Dementia Feb. 2013 



Coffee's Phenylindanes Fight Alzheimer's Plaque 


This also: Two Compounds in Coffee May Team Up to Fight Parkinson's 

Coffee drinking and cancer risk: an umbrella review of meta-analyses of observational studies


Abstract

Background

Epidemiological studies on the association between coffee intake and cancer risk have yielded inconsistent results. To summarize and appraise the quality of the current evidence, we conducted an umbrella review of existing findings from meta-analyses of observational studies.

Methods

We searched PubMed, Embase, Web of Science and the Cochrane database to obtain systematic reviews and meta-analyses of associations between coffee intake and cancer incidence. For each association, we estimated the summary effect size using the fixed- and random-effects model, the 95% confidence interval, and the 95% prediction interval. We also assessed heterogeneity, evidence of small-study effects, and excess significance bias.

Results

Twenty-eight individual meta-analyses including 36 summary associations for 26 cancer sites were retrieved for this umbrella review. A total of 17 meta-analyses were significant at P ≤ 0.05 in the random-effects model. For the highest versus lowest categories, 4 of 26 associations had a more stringent P value (P ≤ 10− 6). Associations for five cancers were significant in dose-response analyses. Most studies (69%) showed low heterogeneity (I2 ≤ 50%). Three and six associations had evidence of excessive significance bias and publication bias, respectively. Coffee intake was inversely related to the risk of liver cancer and endometrial cancer and was characterized by dose-response relationships. There were no substantial changes when we restricted analyses to meta-analysis of cohort studies.

Conclusions

There is highly suggestive evidence for an inverse association between coffee intake and risk of liver and endometrial cancer. Further research is needed to provide more robust evidence for cancer at other sites.



Wednesday, August 9, 2017

Coffee and cancer risk: A summary overview

Good, because I'm using it for many things. You can find whatever proof you want on coffee in these 140 posts on coffee.

Coffee and cancer risk: A summary overview


European Journal of Cancer Prevention
Alicandro G, et al.
This research coveted an appraisal of the present evidence on coffee drinking and the risk of all cancers and selected cancers. Regardless of the mixed nature of the findings, the overall evidence did not display a correlation between coffee intake with cancers of the stomach, pancreas, lung, breast, ovary, and prostate. Data was limited, with the relative risk (RR) close to unity for other neoplasms, with the inclusion of those of the esophagus, small intestine, gallbladder and biliary tract, skin, kidney, brain, thyroid, along with soft tissue sarcoma and lymphohematopoietic cancer.
  • A pooled relative risk (RR) for an increment of 1 cup of coffee/day of 1.00 [95% confidence interval (CI): 0.99-1.01] was noted for all cancers.
  • Coffee drinking was linked to a reduced risk of liver cancer.
  • An RR was found for an increment of consumption of 1 cup/day of 0.85 (95% CI: 0.81-0.90) for liver cancer and a favorable effect on liver enzymes and cirrhosis.
  • Another meta-analysis illustrated an inverse association with endometrial cancer risk, with an RR of 0.92 (95% CI: 0.88-0.96) for an increment of 1 cup/day.
  • A potential decreased risk was detected in few studies for oral/pharyngeal cancer and for advanced prostate cancer.
  • Though the findings were mixed, a certain favorable effect was observed, of coffee drinking on colorectal cancer in case-control studies, in the absence of a consistent relationship in cohort studies.
  • For bladder cancer, the results were not consistent.
  • Any possible direct relation was not dose and duration related.
  • It could depend on a residual confounding effect of smoking.
  • A few studies indicated an increased risk of childhood leukemia after maternal coffee drinking during pregnancy, but data were limited and inconsistent.